Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

APOC1 antibody (AA 35-48) (FITC)

APOC1 Reactivity: Human Host: Rabbit Polyclonal FITC
Catalog No. ABIN7144417
  • Target See all APOC1 Antibodies
    APOC1 (Apolipoprotein C-I (APOC1))
    Binding Specificity
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    AA 35-48
    Reactivity
    • 42
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Host
    • 34
    • 9
    • 5
    • 1
    Rabbit
    Clonality
    • 45
    • 4
    Polyclonal
    Conjugate
    • 27
    • 6
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This APOC1 antibody is conjugated to FITC
    Application
    Please inquire
    Cross-Reactivity
    Human
    Purification
    >95%, Protein G purified
    Immunogen
    Recombinant Human Apolipoprotein C-I protein (35-48aa)
    Isotype
    IgG
    Top Product
    Discover our top product APOC1 Primary Antibody
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    APOC1 (Apolipoprotein C-I (APOC1))
    Alternative Name
    APOC1 (APOC1 Products)
    Synonyms
    Apo-CIB antibody, ApoC-IB antibody, ALPCI antibody, LRRG04 antibody, APOC1 antibody, apoc1 antibody, apolipoprotein C1 antibody, apolipoprotein C-I antibody, Apolipoprotein C-I antibody, APOC1 antibody, Apoc1 antibody, apoc1 antibody
    Background

    Background: Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10 % of the protein of the VLDL and 2 % of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein.

    Aliases: Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I], APOC1

    UniProt
    P02654
    Pathways
    Apoptosis
You are here:
Support